129 related articles for article (PubMed ID: 33723162)
1. Hypericin induces apoptosis in K562 cells via downregulation of
Arani HZ; Olya M; Mirahmadi AS; Saleki H; Atashi HA; Marzouni HZ; Hoseinian M; Javidi MA; Zabolian A
J Cancer Res Ther; 2021; 17(1):242-247. PubMed ID: 33723162
[TBL] [Abstract][Full Text] [Related]
2. Hypericin Induces Apoptosis in MDA-MB-175-VII Cells in Lower Dose Compared to MDA-MB-231.
Abbasi Gamasaee N; Radmansouri M; Ghiasvand S; Shahriari F; Zare Marzouni H; Aryan H; Jangholi E; Javidi MA
Arch Iran Med; 2018 Sep; 21(9):387-392. PubMed ID: 30221528
[TBL] [Abstract][Full Text] [Related]
3. c-Myc antagonizes the effect of p53 on apoptosis and p21WAF1 transactivation in K562 leukemia cells.
Ceballos E; Delgado MD; Gutierrez P; Richard C; Müller D; Eilers M; Ehinger M; Gullberg U; León J
Oncogene; 2000 Apr; 19(18):2194-204. PubMed ID: 10822369
[TBL] [Abstract][Full Text] [Related]
4. Small-molecule MDM2 inhibitor LQFM030-induced apoptosis in p53-null K562 chronic myeloid leukemia cells.
de Oliveira Ribeiro H; Cortez AP; de Ávila RI; da Silva ACG; de Carvalho FS; Menegatti R; Lião LM; Valadares MC
Fundam Clin Pharmacol; 2020 Aug; 34(4):444-457. PubMed ID: 32011031
[TBL] [Abstract][Full Text] [Related]
5. Hypericin Induces Apoptosis in AGS Cell Line with No Significant Effect on Normal Cells.
Naderi M; Rahmani Cherati M; Mohammadian A; Baghery Bidhendy M; Ghiasvand S; Zare Marzouni H; Aryan H; Jangholi E; Javidi MA
Iran J Pharm Res; 2020; 19(3):349-357. PubMed ID: 33680035
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase inhibitors enhance the anticancer activity of nutlin-3 and induce p53 hyperacetylation and downregulation of MDM2 and MDM4 gene expression.
Palani CD; Beck JF; Sonnemann J
Invest New Drugs; 2012 Feb; 30(1):25-36. PubMed ID: 20680659
[TBL] [Abstract][Full Text] [Related]
7. Anticancer Effect and Apoptosis Induction of Gambogic Acid in Human Leukemia Cell Line K562 In Vitro.
Chen J; Zhou M; Zhang Q; Xu J; Ouyang J
Med Sci Monit; 2015 Jun; 21():1604-10. PubMed ID: 26049398
[TBL] [Abstract][Full Text] [Related]
8. Cisplatin in Combination with MDM2 Inhibition Downregulates Rad51 Recombinase in a Bimodal Manner to Inhibit Homologous Recombination and Augment Tumor Cell Kill.
Xie X; He G; Siddik ZH
Mol Pharmacol; 2020 Apr; 97(4):237-249. PubMed ID: 32063580
[TBL] [Abstract][Full Text] [Related]
9. Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis.
Eischen CM; Roussel MF; Korsmeyer SJ; Cleveland JL
Mol Cell Biol; 2001 Nov; 21(22):7653-62. PubMed ID: 11604501
[TBL] [Abstract][Full Text] [Related]
10. Rescue of K562 cells from MDM2-modulated p53-dependent apoptosis by growth factor-induced differentiation.
Mahdi T; Alcalay D; Cognard C; Tanzer J; Kitzis A
Biol Cell; 1998 Dec; 90(9):615-27. PubMed ID: 10085538
[TBL] [Abstract][Full Text] [Related]
11. The anti-cancer peptide, PNC-27, induces tumor cell necrosis of a poorly differentiated non-solid tissue human leukemia cell line that depends on expression of HDM-2 in the plasma membrane of these cells.
Davitt K; Babcock BD; Fenelus M; Poon CK; Sarkar A; Trivigno V; Zolkind PA; Matthew SM; Grin'kina N; Orynbayeva Z; Shaikh MF; Adler V; Michl J; Sarafraz-Yazdi E; Pincus MR; Bowne WB
Ann Clin Lab Sci; 2014; 44(3):241-8. PubMed ID: 25117093
[TBL] [Abstract][Full Text] [Related]
12. Hypericin Exerts Detrimental Effect on Huh-7 As a Delegacy of Hepatocellular Carcinoma: A P53 Dependent Pathway.
Olya M; Zaferani Arani H; Shekarriz A; Zabolian A; Zare Marzouni H; Aryan H; Hoseinian M; Javidi MA; Atashi HA
Galen Med J; 2020; 9():e1896. PubMed ID: 34466606
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic and apoptogenic effect of hypericin, the bioactive component of Hypericum perforatum on the MCF-7 human breast cancer cell line.
Mirmalek SA; Azizi MA; Jangholi E; Yadollah-Damavandi S; Javidi MA; Parsa Y; Parsa T; Salimi-Tabatabaee SA; Ghasemzadeh Kolagar H; Alizadeh-Navaei R
Cancer Cell Int; 2015; 16():3. PubMed ID: 26865836
[TBL] [Abstract][Full Text] [Related]
14. The MDM2 inhibitor CGM097 combined with the BET inhibitor OTX015 induces cell death and inhibits tumor growth in models of neuroblastoma.
Maser T; Zagorski J; Kelly S; Ostrander A; Goodyke A; Nagulapally A; Bond J; Park Y; Saulnier Sholler G
Cancer Med; 2020 Nov; 9(21):8144-8158. PubMed ID: 33034426
[TBL] [Abstract][Full Text] [Related]
15. Gambogic acid down-regulates MDM2 oncogene and induces p21(Waf1/CIP1) expression independent of p53.
Rong JJ; Hu R; Qi Q; Gu HY; Zhao Q; Wang J; Mu R; You QD; Guo QL
Cancer Lett; 2009 Oct; 284(1):102-12. PubMed ID: 19428175
[TBL] [Abstract][Full Text] [Related]
16. Bibenzyl analogue DS-1 inhibits MDM2-mediated p53 degradation and sensitizes apoptosis in lung cancer cells.
Putri HE; Nutho B; Rungrotmongkol T; Sritularak B; Vinayanuwattikun C; Chanvorachote P
Phytomedicine; 2021 May; 85():153534. PubMed ID: 33773191
[TBL] [Abstract][Full Text] [Related]
17. Hsp90 inhibitor BIIB021 enhances triptolide-induced apoptosis of human T-cell acute lymphoblastic leukemia cells in vitro mainly by disrupting p53-MDM2 balance.
Li M; Zhang X; Zhou WJ; Chen YH; Liu H; Liu L; Yang CM; Qan WB
Acta Pharmacol Sin; 2013 Dec; 34(12):1545-53. PubMed ID: 24241349
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of LRRC8A protects human ovarian and alveolar carcinoma cells against Cisplatin-induced expression of p53, MDM2, p21Waf1/Cip1, and Caspase-9/-3 activation.
Sørensen BH; Nielsen D; Thorsteinsdottir UA; Hoffmann EK; Lambert IH
Am J Physiol Cell Physiol; 2016 Jun; 310(11):C857-73. PubMed ID: 26984736
[TBL] [Abstract][Full Text] [Related]
19. Degradation of MDM2 by the interaction between berberine and DAXX leads to potent apoptosis in MDM2-overexpressing cancer cells.
Zhang X; Gu L; Li J; Shah N; He J; Yang L; Hu Q; Zhou M
Cancer Res; 2010 Dec; 70(23):9895-904. PubMed ID: 20935220
[TBL] [Abstract][Full Text] [Related]
20. [Effect and Regulatory Mechanism of Clock Gene Per1 on Biological Behaviors of Human Oral Squamous Carcinoma Cell].
Li HX; Yang K; Fu XJ; Zhao Q
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Apr; 38(2):155-63. PubMed ID: 27181891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
